Impaired subjective well-being in schizophrenia is associated with reduced anterior cingulate activity during reward processing

Psychological Medicine

Volumn 45, Issue 3, 2015, Pages 589-600

  Gilleen, J ^a   Shergill, S S ^a   Kapur, S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Dysphoria; fMRI; reward; schizophrenia; subjective well being

Indexed keywords

ADULT; CASE CONTROL STUDY; CINGULATE GYRUS; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; REACTION TIME; REWARD; SCHIZOPHRENIA;

ADULT; CASE-CONTROL STUDIES; FEMALE; GYRUS CINGULI; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; REACTION TIME; REWARD; SCHIZOPHRENIA;

EID: 84927695762     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291714001718     Document Type: Article

References (46)

1. Abler B, Erk S, Walter H (2007). Human reward system activation is modulated by a single dose of olanzapine in healthy subjects in an event-related, double-blind, placebo-controlled fMRI study. Psychopharmacology 191, 823-833.
2. Abler B, Kammerer H, Frasch K, Spitzer M, Walter H (2008). Altered reward processing in schizophrenic patients treated with olanzapine. Schizophrenia Research 98 (Suppl.), 116.
3. Averbeck B, Evans S, Chouhan V, Bristow E, Shergill SS (2011). Probabilistic learning and inference in schizophrenia. Schizophrenia Research 127, 115-122.
4. Barnes TR (1989). A rating scale for drug-induced akathisia. British Journal of Psychiatry 154, 672-676.
5. Beck AT, Steer RA, Ball R, Ranieri W (1996). Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. Journal of Personality Assessment 67, 588-597.
6. Bench CJ, Friston KJ, Brown RG, Scott LC, Frackowiak RS, Dolan RJ (1992). The anatomy of melancholia - focal abnormalities of cerebral blood flow in major depression. Psychological Medicine 22, 607-615.
7. Chouinard G, Ross-Chouinard A, Annable L, Jones B (1980). The extrapyramidal symptom rating scale. Canadian Journal of Neurological Sciences 7, 233-239.
8. Critchley HD, Mathias CJ, Dolan RJ (2001). Neural activity in the human brain relating to uncertainty and arousal during anticipation. Neuron 29, 537-545.
9. da Silva Alves D, Schmitz N, Figee M, Abeling N, Hasler G, van der Meer J, Nederveen A, de Haan L, Linszen D, van Amelsvoort T (2010). Dopaminergic modulation of the human reward system: a placebo-controlled dopamine depletion fMRI study. Journal of Psychopharmacology 25, 538-549.
10. de Haan L, Lavalaye J, Linszen D, Dingemans PM, Booij J (2000). Subjective experience and striatal dopamine D(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone. American Journal of Psychiatry 157, 1019-1020.
11. Dolan RJ, Fletcher P, Frith CD, Friston KJ, Frackowiak RS, Grasby PM (1995). Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia. Nature 378, 180-182.
12. Friston KJ, Fletcher P, Josephs O, Holmes A, Rugg MD, Turner R (1998). Event-related fMRI: characterizing differential responses. Neuro Image 17, 30-40.
13. Gard DE, Kring AM, Gard MG, Horan WP, Green MF (2007). Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure. Schizophrenia Research 93, 253-260.
14. Haber SN, Knutson B (2010). The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology 35, 4-26.
15. Harvey PO, Pruessner J, Czechowska Y, Lepage M (2007). Individual differences in trait anhedonia: a structural and functional magnetic resonance imaging study in non-clinical subjects. Molecular Psychiatry 12, 767-775.
16. Juckel G, Schlagenhauf F, Koslowski M, Filonov D, Wustenberg T, Villringer A, Knutson B, Kienast T, Gallinat J, Wrase J, Heinz A (2006). Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics. Psychopharmacology 187, 222-228.
17. Karow A, Czekalla J, Dittmann RW, Schacht A, Wagner T, Lambert M, Schimmelmann BG, Naber D (2007). Association of subjective well-being, symptoms, and side effects with compliance after 12 months of treatment in schizophrenia. Journal of Clinical Psychiatry 68, 75-80.
18. Karow A, Naber D (2002). Subjective well-being and quality of life under atypical antipsychotic treatment. Psychopharmacology 162, 3-10.
19. Kay SR, Fiszbein A, Opler LA (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261-276.
20. Keedwell PA, Andrew C, Williams SCR, Brammer MJ, Phillips ML (2005). The neural correlates of anhedonia in major depressive disorder. Biological Psychiatry 58, 843-853.
21. Kirsch P, Schienle A, Stark R, Sammer G, Blecker C, Walter B, Ott U, Burkart J, Vaitl D (2003). Anticipation of reward in a nonaversive differential conditioning paradigm and the brain reward system: an event-related fMRI study. Neuro Image 20, 1086-1095.
22. Knutson B, Adams CM, Fong GW, Hommer D (2001). Anticipation of increasing monetary reward selectively recruits nucleus accumbens. Journal of Neuroscience 21, 159.
23. Knutson B, Bhanji JP, Cooney RE, Atlas LY, Gotlib IH (2008). Neural responses to monetary incentives in major depression. Biological Psychiatry 63, 686-692.
24. Knutson B, Gibbs SEB (2007). Linking nucleus accumbens dopamine and blood oxygenation. Psychopharmacology 191, 812-822.
25. Lambert M, Naber D (2004). Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life. CNS Drugs 18 (Suppl. 2), 5-17.
26. Larisch R, Klimke A, Vosberg H, Loffler S, Gaebel W, Muller-Gartner HW (1997). In vivo evidence for the involvement of dopamine-D2 receptors in striatum and anterior cingulate gyrus in major depression. Neuro Image 5 (Pt 1), 251-260.
27. Lataster J, van Os J, de Haan L, Thewissen B, Bak M, Lataster T, Lardinois M, Delespaul PA, Myin-Germeys I (2010). Emotional experience and estimates of D2 receptor occupancy in psychotic patients treated with haloperidol, risperidone, or olanzapine: an experience sampling study. Journal of Clinical Psychiatry 72, 1397-1404.
28. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH (2003). An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuro Image 19, 1233-1239.
29. Mawlawi O, Martinez D, Slifstein M, Broft A, Chatterjee R, Hwang DR, Huang Y, Simpson N, Ngo K, Van Heertum R, Laruelle M(2001). Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. Journal of Cerebral Blood Flow and Metabolism 21, 1034-1057.
30. Miller DD, Andreasen NC, O'Leary DS, Rezai K, Watkins GL, Ponto LL, Hichwa RD (1997). Effect of antipsychotics on regional cerebral blood flow measured with positron emission tomography. Neuropsychopharmacology 17, 230-240.
31. Mizrahi R, Mamo D, Rusjan P, Graff A, Houle S, Kapur S (2009). The relationship between subjective well-being and dopamine D2 receptors in patients treated with a dopamine partial agonist and full antagonist antipsychotics. International Journal of Neuropsychopharmacology 12, 715-721.
32. Mizrahi R, Rusjan P, Agid O, Graff A, Mamo DC, Zipursky RB, Kapur S (2007). Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia. American Journal of Psychiatry 164, 630-637.
33. Naber D (1995). A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. International Clinical Psychopharmacology 10 (Suppl. 3), 133-138.
34. Naber D, Karow A, Lambert M (2005). Subjective well-being under the neuroleptic treatment and its relevance for compliance. Acta Psychiatrica Scandinavica. Supplementum 427, 29-34.
35. Naber D, Moritz S, Lambert M, Pajonk FG, Holzbach R, Mass R, Andresen B (2001). Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs. Schizophrenia Research 50, 79-88.
36. Nelson HE, Willison JR (1991). The Revised National Adult Reading Test (NART): Test Manual. NFER-Nelson: Windsor.
37. Ochsner KN, Kosslyn SM, Cosgrove GR, Cassem EH, Price BH, Nierenberg AA, Rauch SL (2001). Deficits in visual cognition and attention following bilateral anterior cingulotomy. Neuropsychologia 39, 219-230.
38. Quintana J, Wong T, Ortiz-Portillo E, Marder SR, Mazziotta JC (2004). Anterior cingulated dysfunction during choice anticipation in schizophrenia. Psychiatry Research 132, 117-130.
39. Schlagenhauf F, Juckel G, Koslowski M, Kahnt T, Knutson B, Dembler T, Kienast T, Gallinat J, Wrase J, Heinz A (2007). Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine. Psychopharmacology 196, 673-684.
40. Schlagenhauf F, Sterzer P, Schmack K, Ballmaier M, Rapp M, Wrase J, Juckel G, Gallinat J, Heinz A (2009). Reward feedback alterations in unmedicated schizophrenia patients: relevance for delusions. Biological Psychiatry 65, 1032-1039.
41. Schott BH, Minuzzi L, Krebs RM, Elmenhorst D, Lang M, Winz OH, Seidenbecher CI, Coenen HH, Heinze HJ, Zilles K, Düzel E, Bauer A (2008). Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine release. Journal of Neuroscience 28, 14311-14319.
42. Simpson GM, Angus JW (1970). A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica. Supplementum 212, 11-19.
43. Voruganti L, Awad AG (2004). Neuroleptic dysphoria: towards a new synthesis. Psychopharmacology 171, 121-132.
44. Voruganti L, Slomka P, Zabel P, Costa G, So A, Mattar A, Awad G (2001). Subjective effects of AMPT-induced dopamine depletion in schizophrenia: correlation between dysphoric responses and striatal D(2) binding ratios on SPECT imaging. Neuropsychopharmacology 25, 642-650.
45. Vothknecht S, Meijer C, Zwinderman A, Kikkert M, Dekker J, van Beveren N, Schoevers R, de Haan L; for GROUP (Genetic Risk and Outcome of Psychosis) (2012). Psychometric evaluation of the Subjective Well-being Under Neuroleptic Treatment Scale (SWN) in patients with schizophrenia, their relatives and controls. Psychiatry Research 206, 62-67.
46. Williams ZM, Bush G, Rauch SL, Cosgrove GR, Eskandar EN (2004). Human anterior cingulated neurons and the integration of monetary reward with motor responses. Nature Neuroscience 7, 1370-1375.